Quarterly report · Q1
7730.TEDINET S100SLXV
Period2023-09-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.1bn | 2023-09-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥24.5bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.1bn | 2022-09-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2023-09-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2022-09-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥2.3bn | 2023-09-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.0bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2022-09-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.3bn | 2023-09-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2022-09-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2023-09-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.0bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2022-09-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2023-09-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2022-09-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥54.7bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥55.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥49.1bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥5.1bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥49.5bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥49.8bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥45.0bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.5bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥25.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥15.98 | 2023-09-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.46 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.2 | 2022-09-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.6% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.6% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E02340-000Dentalreportable segment | revenue | 2023-09-01 → 2023-11-30 | ¥2.6bn |
| jpcrp040300-q1r_E02340-000Dentalreportable segment | revenue external | 2023-09-01 → 2023-11-30 | ¥2.6bn |
| jpcrp040300-q1r_E02340-000Dentalreportable segment | segment profit | 2023-09-01 → 2023-11-30 | ¥605m |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | revenue | 2023-09-01 → 2023-11-30 | ¥2.5bn |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | revenue external | 2023-09-01 → 2023-11-30 | ¥2.5bn |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | segment profit | 2023-09-01 → 2023-11-30 | ¥966m |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | revenue | 2023-09-01 → 2023-11-30 | ¥1.9bn |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | revenue external | 2023-09-01 → 2023-11-30 | ¥1.9bn |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | segment profit | 2023-09-01 → 2023-11-30 | ¥651m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2023-11-30 | ¥7.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2023-11-30 | ¥7.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2023-11-30 | ¥2.2bn |
| Reconciling Itemsreconciling | revenue | 2022-09-01 → 2022-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-09-01 → 2022-11-30 | ¥0 |
| jpcrp040300-q1r_E02340-000Dentalreportable segment | revenue | 2022-09-01 → 2022-11-30 | ¥2.4bn |
| jpcrp040300-q1r_E02340-000Dentalreportable segment | revenue external | 2022-09-01 → 2022-11-30 | ¥2.4bn |
| jpcrp040300-q1r_E02340-000Dentalreportable segment | segment profit | 2022-09-01 → 2022-11-30 | ¥677m |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | revenue | 2022-09-01 → 2022-11-30 | ¥2.1bn |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | revenue external | 2022-09-01 → 2022-11-30 | ¥2.1bn |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2022-09-01 → 2022-11-30 | ¥0 |
| jpcrp040300-q1r_E02340-000Eyeless Needlereportable segment | segment profit | 2022-09-01 → 2022-11-30 | ¥595m |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | revenue | 2022-09-01 → 2022-11-30 | ¥1.6bn |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | revenue external | 2022-09-01 → 2022-11-30 | ¥1.6bn |
| jpcrp040300-q1r_E02340-000Surgicalreportable segment | segment profit | 2022-09-01 → 2022-11-30 | ¥476m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2022-11-30 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2022-11-30 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-09-01 → 2022-11-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2022-11-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 356
| Item | Context | Value | Unit |
|---|---|---|---|
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |